Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Xeroderma Pigmentosum D014983 6 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Sneezing D012912 6 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Pelvic Pain D017699 7 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Ear Diseases D004427 7 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Tselepis AD et al. Electrocardiographic alterations induced by AGEPC in Wistar rats in relation to its hypotensive and hematologic effects. 1987 Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. pmid:2885139
Sugiyama T et al. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. 1987 Blood pmid:3580576
Robertson DA et al. Negative inotropic effect of platelet-activating factor on human myocardium: a pharmacological study. 1987 J. Pharmacol. Exp. Ther. pmid:3694533
Nomura H Biological action and structural specificity of diacylglycerol in platelet activation. 1987 Kobe J Med Sci pmid:3695296
Hayashi M et al. Characterization of the activity of a platelet activating factor antagonist, CV-3988. 1987 Jpn. J. Pharmacol. pmid:2888915
Bussolino F et al. Chick retina generates platelet-activating factor. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2890284
Mikashima H et al. An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding. 1987 Jpn. J. Pharmacol. pmid:2890779
McFall TL et al. Effect of group B streptococcal type-specific antigen on polymorphonuclear leukocyte function and polymorphonuclear leukocyte-endothelial cell interaction. 1987 Pediatr. Res. pmid:3037472
Shukla SD et al. Activation of phospholipase C in platelets by platelet activating factor and thrombin causes hydrolysis of a common pool of phosphatidylinositol 4,5-bisphosphate. 1987 Biochim. Biophys. Acta pmid:3036249
Grignani G and Jamieson GA Tissue factor-dependent activation of platelets by cells and microvesicles of SK-OS-10 human osteogenic sarcoma cell line. 1987 Invasion Metastasis pmid:3036740
Snyder F et al. Measurement of key enzyme activities involved in the metabolism of platelet activating factor. 1987 Meth. Enzymol. pmid:3037250
Ingraham LM et al. In vitro and in vivo effects of treatment by platelet-activating factor on N-formyl-met-leu-phe-mediated responses of polymorphonuclear leucocytes. 1987 Br. J. Haematol. pmid:3038160
Criscuoli M and Subissi A Paf-acether-induced death in mice: involvement of arachidonate metabolites and beta-adrenoceptors. 1987 Br. J. Pharmacol. pmid:2880624
Whittle BJ et al. Gastric vascular and mucosal damaging actions of platelet activating factor in the canine stomach. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959063
Englberger W et al. Influence of lysophospholipids and PAF on the oxidative burst of PMNL. 1987 Int. J. Immunopharmacol. pmid:3038761
Handley DA et al. Inhibition by SRI 63-072 and SRI 63-119 of PAF-acether and immune complex effects in the guinea pig. 1987 Eur. J. Pharmacol. pmid:2959489
Doly M et al. Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist. 1987 Immunopharmacology pmid:3038784
Montrucchio G et al. In vitro oxytocic activity of platelet-activating factor on human myometrium. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960158
Homma H et al. Binding and internalization of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in washed rabbit platelets. 1987 J. Biol. Chem. pmid:3038889
Mallet AI et al. Platelet activating factor in chronic plaque psoriasis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960170
Bourgain RH et al. Effect of ginkgolide PAF-acether antagonists on arterial thrombosis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960196
Braquet P et al. Platelet-activating factor: a potential mediator of shock. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960197
Myers A et al. Pharmacological manipulation of platelet-activating factor toxicity in rodents. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960198
Rylander R and Beijer L Inhalation of endotoxin stimulates alveolar macrophage production of platelet-activating factor. 1987 Am. Rev. Respir. Dis. pmid:3541718
Kawaguchi H and Yasuda H Effects of platelet-activating factor on conversion of angiotensin I to II. 1987 FEBS Lett. pmid:3622769
Ninio E et al. Biosynthesis of paf-acether. IX. Role for a phosphorylation-dependent activation of acetyltransferase in antigen-stimulated mouse mast cells. 1987 J. Immunol. pmid:3584983
Casals-Stenzel J Triazolodiazepines are potent antagonists of platelet activating factor (PAF) in vitro and in vivo. 1987 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3587377
Brambilla A et al. WEB 2086. A potent PAF antagonist exerts protective effect toward PAF-induced gastric damage. 1987 Pharmacol Res Commun pmid:3588650
Jancar S et al. Comparative effects of platelet activating factor, leukotriene D4 and histamine on guinea pig trachea, bronchus and lung parenchyma. 1987 Prostaglandins pmid:3588970
Malo PE et al. Enhancement of leukotriene D4-induced contraction of guinea-pig isolated trachea by platelet activating factor. 1987 Prostaglandins pmid:3588971
Joseph R et al. Sensitivity to PAF is increased in migraine patients. 1987 Thromb. Haemost. pmid:3590077
Valone FH Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers. 1987 Thromb. Res. pmid:3590086
Tokumura A et al. Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. 1987 Thromb. Res. pmid:3590110
Bamford CH et al. Polymeric inhibitors of platelet aggregation. II. Copolymers of dipyridamole and related drugs with N-vinylpyrrolidone. 1987 Biochim. Biophys. Acta pmid:3828396
Christman BW et al. Effect of platelet-activating factor on aerosol histamine responsiveness in awake sheep. 1987 Am. Rev. Respir. Dis. pmid:3592402
Robertson DN and Page CP Effect of platelet agonists on airway reactivity and intrathoracic platelet accumulation. 1987 Br. J. Pharmacol. pmid:3664082
Whittle BJ et al. Increased intestinal formation of Paf in endotoxin-induced damage in the rat. 1987 Br. J. Pharmacol. pmid:3664090
Shigenobu K et al. Potentiation by bovine serum albumin (BSA) of endothelium-dependent vasodilator response to acetyl glyceryl ether phosphorylcholine (AGEPC). 1987 J. Pharmacobio-dyn. pmid:3625454
Jensen NJ et al. FAB MS/MS for phosphatidylinositol, -glycerol, -ethanolamine and other complex phospholipids. 1987 Lipids pmid:3626775
Cox CP and Wood KL Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam. 1987 Thromb. Res. pmid:3629553
Ostermann G et al. Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor. 1987 Thromb. Res. pmid:3629555
Pettipher ER et al. PAF-acether in chronic arthritis. 1987 Agents Actions pmid:3630862
Stenmark KR et al. Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. 1987 Am. Rev. Respir. Dis. pmid:3631747
O'Donnell SR and Barnett CJ Microvascular leakage to platelet activating factor in guinea-pig trachea and bronchi. 1987 Eur. J. Pharmacol. pmid:3040440
Haroldsen PE et al. Metabolism of platelet-activating factor in isolated perfused rat lung. 1987 J. Clin. Invest. pmid:3108322
Tahara T et al. PAF antagonistic activity of some thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines. 1987 Chem. Pharm. Bull. pmid:3664818
Hansen JF and Hansen BF [Unstable angina pectoris, acute myocardial infarct, sudden heart death. Patho-anatomy and pathophysiology]. 1987 Ugeskr. Laeg. pmid:3324429
Haroldsen PE et al. Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry. 1987 J. Lipid Res. pmid:3104521
Bienenstock J et al. Mast cell involvement in various inflammatory processes. 1987 Am. Rev. Respir. Dis. pmid:3109295
Levin M et al. Platelet immune complex interaction in the pathogenesis of Kawasaki disease. 1987 Prog. Clin. Biol. Res. pmid:3423040
Violi F et al. Human platelet aggregation by PAF and thromboxane production. 1987 Thromb. Res. pmid:3424290
Muirhead EE Vasodepressor lipid of the renomedullary interstitial cells of the renal papilla is a prohormone activated by the liver. 1987 Agents Actions Suppl. pmid:3324720
Mest HJ et al. Relevance of eicosanoids for biochemical regulation of cardiac rhythm disturbances. 1987 Biomed. Biochim. Acta pmid:3325045
Bloom JW et al. Intravenous platelet activating factor does not affect lung epithelial permeability. 1987 Res. Commun. Chem. Pathol. Pharmacol. pmid:3326081
de Almeida PJ et al. [Biochemical bases of platelet activity in homeostasis and thrombogenesis. III]. 1987 Arq. Bras. Cardiol. pmid:3328601
O'Neill C Embryo-derived platelet activating factor: a preimplantation embryo mediator of maternal recognition of pregnancy. 1987 Domest. Anim. Endocrinol. pmid:3333935
Kester M et al. Elevation of cytosolic free calcium by platelet-activating factor in cultured rat mesangial cells. 1987 FASEB J. pmid:2442057
Chabot MC et al. Reacylation of platelet activating factor with eicosapentaenoic acid in fish-oil-enriched monkey neutrophils. 1987 Biochim. Biophys. Acta pmid:2823907
Wang J and Dunn MJ Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats. 1987 Am. J. Physiol. pmid:2827506
Panetta T et al. Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. 1987 Biochem. Biophys. Res. Commun. pmid:2827647
HÃ¥kansson L et al. New method for the measurement of eosinophil migration. 1987 J. Leukoc. Biol. pmid:2445885
Bazan HE et al. The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products. 1987 Biochem. Biophys. Res. Commun. pmid:2827658
Sciberras DG et al. Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: a double blind investigation. 1987 Br J Clin Pharmacol pmid:2449904
Czarnetzki BM [Mediators and the bronchial system. Pathophysiologic and biochemical aspects of mediators of the bronchial system]. 1987 Wien Med Wochenschr Suppl pmid:3078398
Schwertschlag U et al. L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney. 1987 Circ. Res. pmid:3297384
Page CP A role for platelet activating factor and platelets in the induction of bronchial hyperreactivity. 1987 Int J Tissue React pmid:3298115
Lian EC Pathogenesis of thrombotic thrombocytopenic purpura. 1987 Semin. Hematol. pmid:3299722
Camussi G et al. Release of platelet-activating factor from rabbit heart perfused in vitro by sera with transplantation alloantibodies. 1987 Transplantation pmid:3299910
Tou JS Platelet-activating factor modulates phospholipid acylation in human neutrophils. 1987 Lipids pmid:3110533
Touvay C et al. Gossypol: a potent inhibitor of PAF-acether- and leukotriene-induced contractions of guinea-pig lung parenchyma strips. 1987 J. Pharm. Pharmacol. pmid:2886603
Sudan BJ Ketoconazole, leukotrienes, Paf-acether and nicotine as a hapten: the possible aetiology of seborrhoeic dermatitis. 1987 Med. Hypotheses pmid:2886895
Ostermann G et al. Modification of the polar head group of platelet-activating factor: influence on the biological activity. 1987 Chem. Phys. Lipids pmid:3607969
Bossant MJ et al. Characterization and quantification of PAF-acether (platelet-activating factor) as a heptafluorobutyrate derivative of 1-O-alkyl-2-acetyl-sn-glycerol by capillary column gas chromatography with electron-capture detection. 1987 J. Chromatogr. pmid:3443654
Parker CW Lipid mediators produced through the lipoxygenase pathway. 1987 Annu. Rev. Immunol. pmid:3036183
Shimizu K et al. [Actions of platelet activating factor in pulmonary circulation--experimental investigation using rabbit blood vessel smooth muscle preparations]. 1987 Nihon Kyobu Shikkan Gakkai Zasshi pmid:3444152
Chung KF et al. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. 1987 Lancet pmid:2880069
Casals-Stenzel J and Weber KH Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity. 1987 Br. J. Pharmacol. pmid:2880622
Lagente V et al. Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists. 1987 Braz. J. Med. Biol. Res. pmid:3452452
Gentry PA et al. Inhibitory effect of trichothecene mycotoxins on bovine platelets stimulated by platelet activating factor. 1987 Can. J. Vet. Res. pmid:3453270
Sugatani J et al. Potential involvement of vicinal sulfhydryls in stimulus-induced rabbit platelet activation. 1987 J. Biol. Chem. pmid:2824509
Adnot S et al. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets. 1987 Agents Actions pmid:3115070
Montrucchio G et al. The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition. 1987 Agents Actions pmid:3115072
Spinks NR and O'Neill C Embryo-deprived platelet-activating factor is essential for establishment of pregnancy in the mouse. 1987 Lancet pmid:2432367
Evans TW et al. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. 1987 J. Appl. Physiol. pmid:3115939
Knudsen BS et al. Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. 1987 J. Clin. Invest. pmid:3116043
Feuerstein G and Hallenbeck JM Prostaglandins, leukotrienes, and platelet-activating factor in shock. 1987 Annu. Rev. Pharmacol. Toxicol. pmid:3034139
Bussolino F et al. Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. 1987 J. Immunol. pmid:3116081
Bitterman H et al. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock. 1987 Methods Find Exp Clin Pharmacol pmid:3116357
Gateau O [Role of PAF-acether (platelet activating factor) in cardio-vascular pathology]. 1987 Arch Mal Coeur Vaiss pmid:3117010
Altin JG et al. Evidence that Ca2+ fluxes and respiratory, glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and L-alpha-lysophosphatidylcholine in the perfused rat liver are mediated by products of the cyclo-oxygenase pathway. 1987 Biochem. J. pmid:3117040
Terashita Z et al. A lethal role of platelet activating factor in anaphylactic shock in mice. 1987 J. Pharmacol. Exp. Ther. pmid:3118009
Sperling RI et al. The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes. 1987 J. Immunol. pmid:2826583
de Arriba G et al. Changes in glomerular cross-sectional area induced by platelet activating factor. 1987 Nephrol. Dial. Transplant. pmid:3118261
Darius H and Lefer AM Pharmacologic antagonism of platelet activating factor and peptide leukotrienes inhibits guinea pig anaphylaxis. 1987 Prog. Clin. Biol. Res. pmid:3118384
Musch MW et al. Antigen-and ionophore-stimulated synthesis of platelet-activating factor by the cloned mast cell line, MC9. 1987 Biochem. Biophys. Res. Commun. pmid:3107564
Sisson JH et al. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism. 1987 J. Immunol. pmid:3035016
Michel L et al. Biologic properties of LTB4 and paf-acether in vivo in human skin. 1987 J. Invest. Dermatol. pmid:3035030
Bureau M et al. Desensitization and antagonism of rat polymorphonuclear leukocytes stimulated with PAF acether. 1987 Prostaglandins pmid:3035615
Satouchi K et al. 1-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes. 1987 Lipids pmid:3110532
Di Marzo V et al. Neuropeptides and leukotriene release: effect of peptide histidine isoleucine and secretin in platelet activating factor-stimulated rat lung. 1987 Neuropeptides pmid:3031537